Publications

• Practical Guide for Implementing Cryogenic Electron Microscopy Structure Determination in Dermatology Research.Lomakin IB, Devarkar SC, Freniere C, Bunick CG. J Invest Dermatol. 2025 Jan; 2024 Nov 26. PMID: 39601740.
• Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up).Silverberg JI, Bunick CG, Hong HC, Mendes-Bastos P, Stein Gold L, Costanzo A, Ibrahim N, Sancho C, Wu X, Han Y, Levy G, Altman K, Calimlim B, Eyerich K. Br J Dermatol. 2024 Dec 23. PMID: 39438067.
• Psoriasis: Perspectives from Irwin M. Braverman, MD.Cohen JM, Bunick CG. Clin Dermatol. 2024 Dec 21; 2024 Dec 21. PMID: 39716549.
• Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry.Silverberg JI, Calimlim BM, Grada A, Bunick CG, Gooderham MJ, Shi VY, Obi C, Knapp KD, Munoz B, Crawford JM, Paller AS. J Dermatolog Treat. 2024 Dec; 2024 Dec 11. PMID: 39662888.
• Chemical, Biochemical, and Structural Similarities and Differences of Dermatological cAMP Phosphodiesterase-IV Inhibitors.Wang J, Ho M, Bunick CG. J Invest Dermatol. 2024 Nov 27; 2024 Nov 27. PMID: 39608668.
• Mechanistic Basis for the Translation Inhibition of Cutibacterium acnes by Clindamycin.Lomakin IB, Devarkar SC, Grada A, Bunick CG. J Invest Dermatol. 2024 Nov; 2024 Aug 8. PMID: 39122144.
• Crystal Structure of Bimekizumab Fab Fragment in Complex with IL-17F Provides Molecular Basis for Dual IL-17A and IL-17F Inhibition.Adams R, Bunick CG, Lawson ADG, Gomez B, Shaw S. J Invest Dermatol. 2024 Nov; 2024 Apr 16. PMID: 38631666.
• Evaluation of Benzene Presence and Formation in Benzoyl Peroxide Drug Products.Kucera K, Zenzola N, Hudspeth A, Dubnicka M, Hinz W, Bunick CG, Girardi M, Dabestani A, Light DY. J Invest Dermatol. 2024 Oct 7; 2024 Oct 7. PMID: 39384016.
• Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Male and Female Acne: Phase 3 Analysis.Lain ET, Bhatia N, Kircik L, Gold LS, Harper JC, Bunick CG, Guenin E, Baldwin H, Feldman SR, Rosso JQD. J Drugs Dermatol. 2024 Oct 1. PMID: 39361705.
• Structural Insights: What Makes Some IL-23 Biologics More Effective in Psoriasis.Daniele SG, Galimberti F, Bunick CG. J Drugs Dermatol. 2024 Oct 1. PMID: 39361690.
• In response to Reynolds et al's "guidelines of care for the management of acne vulgaris".Issa NT, Bunick CG. J Am Acad Dermatol. 2024 Oct; 2024 Jun 21. PMID: 38909659.
• Alterations in the Skin Microbiome in Dermatologic Diseases and with External Exposures: CME Part 2.MacGibeny MA, Adjei S, Pyle H, Bunick CG, Ghannoum M, Grada A, Harris-Tryon T, Tyring SK, Kong HH. J Am Acad Dermatol. 2024 Aug 20; 2024 Aug 20. PMID: 39173885.
• The Human Skin Microbiome in Health: CME Part 1.MacGibeny MA, Adjei S, Pyle H, Bunick CG, Ghannoum M, Grada A, Harris-Tryon T, Tyring SK, Kong HH. J Am Acad Dermatol. 2024 Aug 19; 2024 Aug 19. PMID: 39168311.
• Clindamycin: A Comprehensive Status Report with Emphasis on Use in Dermatology.Del Rosso JQ, Armillei MK, Lomakin IB, Grada A, Bunick CG. J Clin Aesthet Dermatol. 2024 Aug. PMID: 39148960.
• Rapid Remission of Plaque Psoriasis With Bimekizumab Treatment.Abdin R, Gharib R, Bunick CG, Issa NT. J Drugs Dermatol. 2024 Aug 1. PMID: 39093648.
• Topical Clindamycin in the Management of Acne Vulgaris: Current Perspectives and Recent Therapeutic Advances.Del Rosso JQ, Bunick CG, Kircik L, Bhatia N. J Drugs Dermatol. 2024 Jun 1. PMID: 38834223.
• Unveiling the secrets of vimentin filament architecture relevant to human disease.Lomakin IB, Ho M, Bunick CG. Nat Struct Mol Biol. 2024 Jun. PMID: 38684931.
• Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis.Kircik LH, Stein Gold L, Gold M, Weiss JS, Harper JC, Del Rosso JQ, Bunick CG, Bhatia N, Tanghetti EA, Eichenfield LF, Baldwin H, Draelos ZD, Callender VD, Han G, Gooderham MJ, Sadick N, Lupo MP, Lain ET, Werschler WP. Dermatol Ther (Heidelb). 2024 May; 2024 May 9. PMID: 38724841.
• Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2).Silverberg JI, Gooderham MJ, Paller AS, Deleuran M, Bunick CG, Gold LFS, Hijnen D, Calimlim BM, Lee WJ, Teixeira HD, Hu X, Zhang S, Yang Y, Grada A, Platt AM, Thaçi D. Am J Clin Dermatol. 2024 May; 2024 Mar 25. PMID: 38528257.
• Altered skin microbiome, inflammation, and JAK/STAT signaling in Southeast Asian ichthyosis patients.Ho M, Nguyen HN, Van Hoang M, Bui TTT, Vu BQ, Dinh THT, Vo HTM, Blaydon DC, Eldirany SA, Bunick CG, Bui CB. Hum Genomics. 2024 Apr 16; 2024 Apr 16. PMID: 38627868.
• Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease.Armillei MK, Lomakin IB, Del Rosso JQ, Grada A, Bunick CG. Antibiotics (Basel). 2024 Mar 17; 2024 Mar 17. PMID: 38534705.
• Rethinking Hidradenitis Suppurativa Management: Insights into Bacterial Interactions and Treatment Evolution.Huynh FD, Damiani G, Bunick CG. Antibiotics (Basel). 2024 Mar 17; 2024 Mar 17. PMID: 38534703.
• Benzoyl Peroxide Drug Products Form Benzene.Kucera K, Zenzola N, Hudspeth A, Dubnicka M, Hinz W, Bunick CG, Dabestani A, Light DY. Environ Health Perspect. 2024 Mar; 2024 Mar 14. PMID: 38483533.
• Structural Basis for p19 Targeting by Anti-IL-23 Biologics: Correlations with Short- and Long-Term Efficacy in Psoriasis.Daniele SG, Eldirany SA, Damiani G, Ho M, Bunick CG. JID Innov. 2024 Mar; 2024 Jan 20. PMID: 38445231.
• Triple-action inhibitory mechanism of allosteric TYK2-specific inhibitors.Wang J, Batista VS, Bunick CG. bioRxiv. 2023 Oct 9; 2023 Oct 9. PMID: 37873392.
• Ensuring Dermatologists Practice Enhanced Antibiotic Stewardship With Sarecycline Mnemonic.Borash J, Bunick CG, Graber E. J Drugs Dermatol. 2023 Oct 1. PMID: 37801533.
• Circadian Oscillations of Minimal Erythema Dose (MED) are Also Influenced by Diet in Patients with Psoriasis: A Chronomedical Study.Damiani G, Pacifico A, Scoditti E, di Gregorio S, Del Fabbro M, Cozzolino C, Buja A, Mercuri SR, Bianchi VG, Grada A, Garbarino S, Bunick CG. Dermatol Ther (Heidelb). 2023 Oct; 2023 Aug 12. PMID: 37573289.
• Acne accounts for an almost 2.5-fold higher proportion of dermatology visits among adult females compared to adult males in the United States: A study of the national ambulatory medical care survey from 2002-2016.Chang J, Nock MR, Cohen JM, Bunick CG. PLoS One. 2023; 2023 Sep 21. PMID: 37733776.
• Antimicrobial Wound Dressings: A Concise Review for Clinicians.Yousefian F, Hesari R, Jensen T, Obagi S, Rgeai A, Damiani G, Bunick CG, Grada A. Antibiotics (Basel). 2023 Sep 11; 2023 Sep 11. PMID: 37760730.
• Congenital Ichthyosis: A Practical Clinical Guide on Current Treatments and Future Perspectives.Lilly E, Bunick CG. Clin Cosmet Investig Dermatol. 2023; 2023 Sep 11. PMID: 37719935.
• Demystifying Hand Eczema.Grada A, Bunick CG. J Invest Dermatol. 2023 Aug; 2023 Apr 27. PMID: 37115112.
• Characteristics and outcomes for participants with congenital ichthyosis who responded to treatment with the topical isotretinoin formulation TMB-001: results from the Phase IIb CONTROL study.Bunick CG, Teng JMC, Guenthner S, Marathe K, Kempers S, Eads K, Castelo-Soccio L, Mendelsohn AM, Raiz J, Murrell DF. Clin Exp Dermatol. 2023 Jul 7. PMID: 36928932.
• Phase IIb randomized CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked or autosomal recessive lamellar congenital ichthyosis.Murrell DF, Teng JMC, Guenthner S, Marathe K, Kempers S, Eads K, Castelo-Soccio L, Mendelsohn AM, Raiz J, Bunick CG. Clin Exp Dermatol. 2023 Jun 5. PMID: 36794376.
• Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the Phase 2b CONTROL Study.Marathe K, Teng JMC, Guenthner S, Bunick CG, Kempers S, Eads K, Castelo-Soccio L, Mendelsohn AM, Raiz J, Murrell DF. Dermatol Ther (Heidelb). 2023 Jun; 2023 May 11. PMID: 37170057.
• Sarecycline inhibits protein translation in Cutibacterium acnes 70S ribosome using a two-site mechanism.Lomakin IB, Devarkar SC, Patel S, Grada A, Bunick CG. Nucleic Acids Res. 2023 Apr 11. PMID: 36864821.
• Inguinal patch in mpox (monkeypox) virus infection and eccrine syringometaplasia: report of two cases with in situ hybridization and electron microscopy findings.Roy SF, Sarhan J, Liu X, Murphy MJ, Bunick CG, Choate KA, Damsky WB, McNiff JM. Br J Dermatol. 2023 Mar 30. PMID: 36763786.
• Structural basis for differential p19 targeting by IL-23 biologics.Daniele SG, Eldirany SA, Ho M, Bunick CG. bioRxiv. 2023 Mar 9; 2023 Mar 9. PMID: 36945513.
• Trends in Oral Antibiotic Use for Acne Treatment: A Retrospective, Population-Based Study in the United States, 2014 to 2016.Grada A, Armstrong A, Bunick C, Salem R, Feldman S. J Drugs Dermatol. 2023 Mar 1. PMID: 36877883.
• Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management.Daniele SG, Kim SR, Grada A, Moore AY, Suozzi KC, Bunick CG. Am J Clin Dermatol. 2023 Mar; 2022 Dec 20. PMID: 36539678.
• Reduced blood-brain barrier penetration of acne vulgaris antibiotic sarecycline compared to minocycline corresponds with lower lipophilicity.Grada A, Del Rosso JQ, Moore AY, Stein Gold L, Harper J, Damiani G, Shaw K, Obagi S, Salem RJ, Tanaka SK, Bunick CG. Front Med (Lausanne). 2022; 2022 Dec 8. PMID: 36569144.
• JAK Inhibitor Safety Compared to Traditional Systemic Immunosuppressive Therapies.Daniele S, Bunick C. J Drugs Dermatol. 2022 Dec 1. PMID: 36468956.
• The CONTROL study: A randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosis.Teng JMC, Bunick CG, Guenthner S, Murrell DF, Marathe K, Kempers S, Eads K, Mendelsohn AM, Raiz J, Tavakkol A, Castelo-Soccio L. J Am Acad Dermatol. 2022 Dec; 2022 Jul 21. PMID: 35872261.
• Safety, tolerability, and efficacy of a novel topical isotretinoin formulation for the treatment of X-linked or lamellar congenital ichthyosis: Results from a phase 2a proof-of-concept study.Paller AS, Browning J, Parish LC, Bunick CG, Rome Z, Bhatia N. J Am Acad Dermatol. 2022 Nov; 2022 Mar 7. PMID: 35271936.
• Stenotrophomonas maltophilia, a Pathogen of Increasing Relevance to Dermatologists: A Case Report and Review of the Literature.Belzer A, Weiss E, Etaee F, Bunick CG, Damsky W, Nelson CA. Antibiotics (Basel). 2022 Oct 12; 2022 Oct 12. PMID: 36290055.
• Antibiotic Resistance Risk with Oral Tetracycline Treatment of Acne Vulgaris.Swallow MA, Fan R, Cohen JM, Bunick CG. Antibiotics (Basel). 2022 Jul 30; 2022 Jul 30. PMID: 36009899.
• Sarecycline Demonstrates Clinical Effectiveness against Staphylococcal Infections and Inflammatory Dermatoses: Evidence for Improving Antibiotic Stewardship in Dermatology.Grada A, Ghannoum MA, Bunick CG. Antibiotics (Basel). 2022 May 27; 2022 May 27. PMID: 35740129.
• Sarecycline treatment for acne vulgaris: Rationale for weight-based dosing and limited impact of food intake on clinical efficacy.Grada A, Del Rosso JQ, Graber E, Bunick CG, Stein Gold L, Moore AY, Baldwin H, Obagi Z, Damiani G, Carrothers T, McNamee B, Hanze E. Dermatol Ther. 2022 Mar; 2021 Dec 30. PMID: 34923732.
• Sarecycline Demonstrated Reduced Activity Compared to Minocycline against Microbial Species Representing Human Gastrointestinal Microbiota.Ghannoum MA, Long L, Bunick CG, Del Rosso JQ, Gamal A, Tyring SK, McCormick TS, Grada A. Antibiotics (Basel). 2022 Feb 28; 2022 Feb 28. PMID: 35326788.
• Update of the keratin gene family: evolution, tissue-specific expression patterns, and relevance to clinical disorders.Ho M, Thompson B, Fisk JN, Nebert DW, Bruford EA, Vasiliou V, Bunick CG. Hum Genomics. 2022 Jan 6; 2022 Jan 6. PMID: 34991727.
• Keratin 1 as a cell-surface receptor in cancer.Ogunnigbagbe O, Bunick CG, Kaur K. Biochim Biophys Acta Rev Cancer. 2022 Jan; 2021 Dec 7. PMID: 34890750.
• Genotype‒Structurotype‒Phenotype Correlations in Patients with Pachyonychia Congenita.Wu TT, Eldirany SA, Bunick CG, Teng JMC. J Invest Dermatol. 2021 Dec; 2021 Jun 8. PMID: 34116063.
• Dermatomyositis associated with an adrenal adenoma.Eldirany SA, Ring N, Laskin W, Bunick CG. JAAD Case Rep. 2021 Jun; 2021 Apr 28. PMID: 34041336.
• Antibacterial Mechanisms and Efficacy of Sarecycline in Animal Models of Infection and Inflammation.Bunick CG, Keri J, Tanaka SK, Furey N, Damiani G, Johnson JL, Grada A. Antibiotics (Basel). 2021 Apr 15; 2021 Apr 15. PMID: 33920812.
• Spectrum of Antibiotic Activity and Its Relevance to the Microbiome.Grada A, Bunick CG. JAMA Netw Open. 2021 Apr 1; 2021 Apr 1. PMID: 33914053.
• Recent insight into intermediate filament structure.Eldirany SA, Lomakin IB, Ho M, Bunick CG. Curr Opin Cell Biol. 2021 Feb; 2020 Nov 12. PMID: 33190098.
• Patient and physician perspectives on teledermatology at an academic dermatology department amid the COVID-19 pandemic.Asabor EN, Bunick CG, Cohen JM, Perkins SH. J Am Acad Dermatol. 2021 Jan; 2020 Sep 15. PMID: 32946971.
• The new normal: An approach to optimizing and combining in-person and telemedicine visits to maximize patient care.Cohen JM, Bunick CG, Perkins SH. J Am Acad Dermatol. 2020 Nov; 2020 Jun 25. PMID: 32593636.
• Structural properties of target binding by profilaggrin A and B domains and other S100 fused-type calcium-binding proteins.Hinbest AJ, Kim SR, Eldirany SA, Lomakin IB, Watson J, Ho M, Bunick CG. J Dermatol Sci. 2020 Oct; 2020 Aug 21. PMID: 32893105.
• Molecular Modeling of Pathogenic Mutations in the Keratin 1B Domain.Hinbest AJ, Eldirany SA, Ho M, Bunick CG. Int J Mol Sci. 2020 Sep 10; 2020 Sep 10. PMID: 32927888.
• Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome.Batool Z, Lomakin IB, Polikanov YS, Bunick CG. Proc Natl Acad Sci U S A. 2020 Aug 25; 2020 Aug 12. PMID: 32817463.
• Teledermatology in the era of COVID-19: Experience of an academic department of dermatology.Perkins S, Cohen JM, Nelson CA, Bunick CG. J Am Acad Dermatol. 2020 Jul; 2020 Apr 17. PMID: 32305442.
• CD8(+) mycosis fungoides palmaris et plantaris with peripheral blood involvement.Yumeen S, Mirza FN, Lewis JM, Carlson KR, King B, Cowper S, Bunick CG, McNiff J, Girardi M. JAAD Case Rep. 2020 May; 2020 Apr 30. PMID: 32382639.
• Structural Basis for How Biologic Medicines Bind their Targets in Psoriasis Therapy.Eldirany SA, Ho M, Bunick CG. Yale J Biol Med. 2020 Mar; 2020 Mar 27. PMID: 32226331.
• Crystal Structure of Keratin 1/10(C401A) 2B Heterodimer Demonstrates a Proclivity for the C-Terminus of Helix 2B to Form Higher Order Molecular Contacts.Lomakin IB, Hinbest AJ, Ho M, Eldirany SA, Bunick CG. Yale J Biol Med. 2020 Mar; 2020 Mar 27. PMID: 32226330.
• The Interface between Keratin Structurotype and Human Disease.Eldirany SA, Ho M, Bunick CG. Structure. 2020 Mar 3. PMID: 32130887.
• Ixekizumab-induced alopecia areata.Eldirany SA, Myung P, Bunick CG. JAAD Case Rep. 2020 Jan; 2019 Dec 26. PMID: 31909139.
• Successful management of malodor from fungating tumors using crushed metronidazole tablets.Hu JK, Ligtenberg KG, Leventhal J, Bunick CG. JAAD Case Rep. 2020 Jan; 2019 Dec 24. PMID: 31909133.
• Alterations in connexin 26 protein structure from lethal keratitis-ichthyosis-deafness syndrome mutations A88V and G45E.Lilly E, Strickler M, Milstone LM, Bunick CG. J Dermatol Sci. 2019 Sep; 2019 Jul 10. PMID: 31331740.
• Human keratin 1/10-1B tetramer structures reveal a knob-pocket mechanism in intermediate filament assembly.Eldirany SA, Ho M, Hinbest AJ, Lomakin IB, Bunick CG. EMBO J. 2019 Jun 3; 2019 Apr 29. PMID: 31036554.
• More than keratitis, ichthyosis, and deafness: Multisystem effects of lethal GJB2 mutations.Lilly E, Bunick CG, Maley AM, Zhang S, Spraker MK, Theos AJ, Vivar KL, Seminario-Vidal L, Bennett AE, Sidbury R, Ogawa Y, Akiyama M, Binder B, Hadj-Rabia S, Morotti RA, Glusac EJ, Choate KA, Richard G, Milstone LM. J Am Acad Dermatol. 2019 Mar; 2018 Oct 2. PMID: 30287322.
• Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure.Haugh AM, Zhang B, Quan VL, Garfield EM, Bubley JA, Kudalkar E, Verzi AE, Walton K, VandenBoom T, Merkel EA, Lee CY, Tan T, Isales MC, Kong BY, Wenzel AT, Bunick CG, Choi J, Sosman J, Gerami P. J Invest Dermatol. 2018 Feb; 2017 Sep 1. PMID: 28870692.
• The X-Ray Crystal Structure of the Keratin 1-Keratin 10 Helix 2B Heterodimer Reveals Molecular Surface Properties and Biochemical Insights into Human Skin Disease.Bunick CG, Milstone LM. J Invest Dermatol. 2017 Jan; 2016 Sep 3. PMID: 27595935.
• Koebnerization of Hailey-Hailey disease into a cutaneous drug eruption of acute generalized exanthematous pustulosis associated with systemic symptoms.Totonchy MB, McNiff JM, Bunick CG. J Cutan Pathol. 2016 Nov; 2016 Aug 22. PMID: 27433827.
• Nonoverlapping Clinical and Mutational Patterns in Melanomas from the Female Genital Tract and Atypical Genital Nevi.Yélamos O, Merkel EA, Sholl LM, Zhang B, Amin SM, Lee CY, Guitart GE, Yang J, Wenzel AT, Bunick CG, Yazdan P, Choi J, Gerami P. J Invest Dermatol. 2016 Sep; 2016 May 21. PMID: 27220476.
• Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy.Suozzi KC, Stahl M, Ko CJ, Chiang A, Gettinger SN, Siegel MD, Bunick CG. JAAD Case Rep. 2016 May; 2016 Jul 14. PMID: 27486590.
• Eczema craquelé associated with nephrotic syndrome.Yang CS, Lott JP, Bunick CG, Bolognia JL. JAAD Case Rep. 2016 May; 2016 Jun 24. PMID: 27408932.
• Genomic landscape of cutaneous T cell lymphoma.Choi J, Goh G, Walradt T, Hong BS, Bunick CG, Chen K, Bjornson RD, Maman Y, Wang T, Tordoff J, Carlson K, Overton JD, Liu KJ, Lewis JM, Devine L, Barbarotta L, Foss FM, Subtil A, Vonderheid EC, Edelson RL, Schatz DG, Boggon TJ, Girardi M, Lifton RP. Nat Genet. 2015 Sep; 2015 Jul 20. PMID: 26192916.
• Crystal Structure of Human Profilaggrin S100 Domain and Identification of Target Proteins Annexin II, Stratifin, and HSP27.Bunick CG, Presland RB, Lawrence OT, Pearton DJ, Milstone LM, Steitz TA. J Invest Dermatol. 2015 Jul; 2015 Mar 11. PMID: 25760235.
• Perspectives on physiology and medicine from Nobel Prize Winners: the 64th Lindau Nobel Laureate Meeting.Bunick CG. J Invest Dermatol. 2014 Dec. PMID: 25381760.
• The role of infliximab in the treatment of superficial granulomatous pyoderma of the head and neck.Ibrahim O, Bunick CG, Srivastava B, Lazova R, Ko CJ, Watsky KL. J Am Acad Dermatol. 2014 Nov; 2014 Oct 15. PMID: 25438004.
• When erythema ab igne warrants an evaluation for internal malignancy.Bunick CG, King BA, Ibrahim O. Int J Dermatol. 2014 Jul; 2014 Mar 6. PMID: 24601874.
• Midodrine-induced acute generalized exanthematous pustulosis.Sadeghpour M, Bunick CG, Robinson DM, Galan A, Tigelaar RE, Imaeda S. Cutis. 2014 May. PMID: 24897147.
• Vegetative plaques and hemorrhagic pustules. Iododerma.Stavert R, Bunick CG, Modi B, Robinson DM, Ibrahim O, Knopp E, Tigelaar R, Imaeda S. JAMA Dermatol. 2013 Oct. PMID: 23925362.
• Expanding the histologic findings in smallpox-related post-vaccinial non-viral folliculitis.Bunick CG, Mariwalla K, Ibrahim O, Modi B, Imaeda S, McNiff JM. J Cutan Pathol. 2013 Mar; 2012 Dec 20. PMID: 23278890.
• Development of a plaque infiltrated with large CD30+ T cells over a silicone-containing device in a patient with history of Sézary syndrome.Engberg AK, Bunick CG, Subtil A, Ko CJ, Girardi M. J Clin Oncol. 2013 Feb 20; 2012 Nov 26. PMID: 23182990.
• Cutaneous Rosai-Dorfman disease of the right ear responsive to radiotherapy.Bunick CG, Leffell D, Bosenberg M, Yahalom J, Choi JN. J Am Acad Dermatol. 2012 Nov. PMID: 23062927.
• Chemical burn from topical apple cider vinegar.Bunick CG, Lott JP, Warren CB, Galan A, Bolognia J, King BA. J Am Acad Dermatol. 2012 Oct. PMID: 22980269.
• Hemorrhagic complications in dermatologic surgery.Bunick CG, Aasi SZ. Dermatol Ther. 2011 Nov-Dec. PMID: 22515669.
• Serum sickness-like reaction: histopathology and case report.Tolpinrud WL, Bunick CG, King BA. J Am Acad Dermatol. 2011 Sep. PMID: 21839305.
• Biochemical and structural domain analysis of xeroderma pigmentosum complementation group C protein.Bunick CG, Miller MR, Fuller BE, Fanning E, Chazin WJ. Biochemistry. 2006 Dec 19. PMID: 17154534.
• Structure of the N-terminal calcium sensor domain of centrin reveals the biochemical basis for domain-specific function.Sheehan JH, Bunick CG, Hu H, Fagan PA, Meyn SM, Chazin WJ. J Biol Chem. 2006 Feb 3; 2005 Nov 29. PMID: 16317001.
• Two blades of the [ex]scissor.Bunick CG, Chazin WJ. Structure. 2005 Dec. PMID: 16338401.
• Target selectivity in EF-hand calcium binding proteins.Bhattacharya S, Bunick CG, Chazin WJ. Biochim Biophys Acta. 2004 Dec 6. PMID: 15590057.
• Designing sequence to control protein function in an EF-hand protein.Bunick CG, Nelson MR, Mangahas S, Hunter MJ, Sheehan JH, Mizoue LS, Bunick GJ, Chazin WJ. J Am Chem Soc. 2004 May 19. PMID: 15137763.